Thomas Flaig

A medical oncologist, Dr. Flaig has been part of the University of Colorado since 2003, when he arrived as a fellow. He has previously served in the research leadership of the University of Colorado Cancer Center, as medical director of the cancer clinical trials office and as associate director for clinical research at CU Anschutz.  In 2016, he became the inaugural chief clinical research officer of UCHealth and associate dean for clinical research at the CU School of Medicine. In this role, he led numerous efforts to establish an efficient and optimal environment for conducting research across the campus while coordinating research activities with the university’s clinical partners.

In addition to his clinical and administrative work, Dr. Flaig has significant clinical and translational research experience, having led both local and national multi-center clinical trials and served as a principal investigator on a multitude of Phase I, II and III oncology studies. 

Known nationally for his urologic oncology cancer research, Dr. Flaig has been a member of the National Cancer Institute’s Bladder Cancer Task Force. He also serves as chair of the bladder cancer committee for the National Comprehensive Care Network, which regularly publishes internationally recognized treatment guidelines, and co-Chairs the SWOG bladder cancer subcommittee.

In addition, he has personal experience with the translation of lab discoveries to the clinic, having founded a small business with Small Business Innovation Research (SBIR) funding to advance work done in his lab and associated patents.